Transparency Report means a transparency report in connection with reporting payments and other transfers of value made to health care professionals, including, without limitation, investigators, steering committee members, data monitoring committee members, and consultants in connection with the Study in accordance with reporting requirements under Applicable Law, including, without limitation, the Physician Payment Sunshine Act and state gift laws, and the European Federation of Pharmaceutical Industries and Associations Disclosure Code, or a Party’s applicable policies.
Transparency Report has the meaning set forth in Section 3.4(k)(vii).
Transparency Report has the meaning specified in Section 13.23(b) hereof.
Examples of Transparency Report in a sentence
Annual Debt Transparency Report ("ADTR") filings will be submitted to the California Debt and Investment Advisory Commission ("CDIAC") for all debt obligations issued on or after January 21, 2017 pursuant to Senate Bill No. 1029.
More Definitions of Transparency Report
Transparency Report a document presenting all public Indicators relevant to a particular signatory and an individual signatory’s responses to those Indicators. PRI will disclose a signatory’s Transparency Report on the website after it has submitted a response to the Reporting Framework.
Transparency Report has the meaning set forth in Section 4.4.
Transparency Report is the publicly available report including information regarding requests made by government agencies or law enforcement officials to obtain Personal Data from Insycle and that is located at xxxxx://xxx.xxxxxxx.xxx/transparencyreport or at such other URL as Insycle may provide from time to time.
Transparency Report means a transparency report accessed via the Data Portal showing your responses to Indicators provided through the Reporting Tool.
Transparency Report means a transparency report in connection with reporting payments and other transfers of value made to health care professionals, including, without limitation, investigators, steering committee members, data monitoring committee members, and consultants in connection with the Study in accordance with reporting requirements under Applicable Law, *** INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24B-2 PROMULGATED UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED. including, without limitation, the Physician Payment Sunshine Act and state gift laws, and the European Federation of Pharmaceutical Industries and Associations Disclosure Code, or a Party’s applicable policies.”
Transparency Report means a transparency report in connection with reporting payments and other transfers of value made to health care professionals, including, without limitation, investigators, steering committee members, data monitoring committee members, and consultants in connection with the Study in accordance with reporting requirements under Applicable Law, including, without limitation, the Physician Payment Sunshine Act and state gift laws, and the European Federation of Pharmaceutical Industries and Associations Disclosure Code, or a Party’s applicable policies. *** Portions of this page have been omitted pursuant to a request for Confidential Treatment filled separately with the Commission. Execution Version
Transparency Report means a transparency report in connection with reporting payments and other transfers of value made to health care providers or health care professionals, including, as applicable and without limitation, Study sites, investigators, steering committee members, data monitoring committee members, and consultants in connection with the Study in accordance with reporting requirements under Applicable Law, including, without limitation, the Physician Payment Sunshine Act and state gift laws, and the European Federation of Pharmaceutical Industries and Associations Disclosure Code, or a Party’s applicable policies. [***] INDICATES MATERIAL THAT WAS OMITTED AND FOR WHICH CONFIDENTIAL TREATMENT WAS REQUESTED. ALL SUCH OMITTED MATERIAL WAS FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION PURSUANT TO RULE 24b-2 UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS AMENDED.